Processa Pharmaceuticals Inc (PCSA)
1.58
+0.02
(+1.28%)
USD |
NASDAQ |
Apr 19, 16:00
1.58
0.00 (0.00%)
After-Hours: 16:55
Processa Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2016 | -0.6526 |
| December 31, 2015 | -0.6905 |
| September 30, 2015 | -1.022 |
| June 30, 2015 | -1.280 |
| March 31, 2015 | 2.011 |
| December 31, 2014 | 0.4723 |
| September 30, 2014 | -21.48 |
| June 30, 2014 | 3.041 |
| Date | Value |
|---|---|
| March 31, 2014 | 1.588 |
| December 31, 2013 | 0.4648 |
| September 30, 2013 | 0.5034 |
| June 30, 2013 | 2.089 |
| March 31, 2013 | 0.6492 |
| December 31, 2012 | 0.4423 |
| September 30, 2012 | 0.3737 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 5.787M |
| Total Liabilities (Quarterly) | 0.7975M |
| Shareholders Equity (Quarterly) | 4.989M |